1,486
Views
16
CrossRef citations to date
0
Altmetric
Research Article

A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability

, ORCID Icon, , ORCID Icon, , , , , , & show all
Pages 240-247 | Received 28 Jul 2016, Accepted 20 Sep 2016, Published online: 18 Jan 2017

References

  • Sau A, Pellizzari Tregno F, Valentino F, et al. Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys 2010;500:116–22.
  • Ricci G, De Maria F, Antonini G, et al. 7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-transferases. Mechanism of action of potential anticancer drugs. J Biol Chem 2005;280:26397–405.
  • Turella P, Cerella C, Filomeni G, et al. Proapoptotic activity of new glutathione S-transferase inhibitors. Cancer Res 2005;65:3751–61.
  • De Luca A, Federici L, De Canio M, et al. New insights into the mechanism of JNK1 inhibition by glutathione transferase P1-1. Biochemistry 2012;51:7304–12.
  • Sau A, Filomeni G, Pezzola S, et al. MTargeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines. Mol Biosyst 2012;8:994–1006.
  • De Luca A, Mei G, Rosato N, et al. The fine-tuning of TRAF2–GSTP1-1 interaction: effect of ligand binding and in situ detection of the complex. Cell Death Dis 2014;5:e1015.
  • Pellizzari Tregno F, Sau A, Pezzola S, et al. In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma. Eur J Cancer 2009;45:2606–17.
  • Tentori L, Dorio AS, Mazzon E, et al. The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma. Eur J Cancer 2011;47:1219–30.
  • Rotili D, De Luca A, Tarantino D, et al. Synthesis and structure–activity relationship of new cytotoxic agents targeting human glutathione-S-transferases. Eur J Med Chem 2015;89:156–71.
  • Stella L, van de Weert M. Fluorescence quenching and ligand binding: a critical discussion of a popular methodology. J Mol Struct 2011;998:144–50.
  • Ricci G, Caccuri AM, Lo Bello M, et al. Glutathione transferase P1-1: self-preservation of an anti-cancer enzyme. Biochem J 2003;376:71–6.
  • De Luca A, Rotili D, Carpanese D, et al. A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts. Oncotarget 2015;6:4126–43.
  • Hegazy UM, Mannervik B, Stenberg G. Functional role of the lock and key motif at the subunit interface of glutathione transferase p1-1. J Biol Chem 2004;279:9586–96.
  • Wu Y, Fan Y, Xue B, et al. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 2006;25:5787–800.